Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide + Decitabine in R/R MDS
NCT06923488Phase 2Recruiting
- Sponsor
- West Virginia University
- Start
- Jul 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide in myelodysplastic syndrome (MDS), sponsored by West Virginia University. Started Jul 2025; status: recruiting.
02
Drugs
leflunomide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT06923488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06923488.